666
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Simultaneous analysis of aliskiren and hydrochlorothiazide in pharmaceutical preparations and spiked human plasma by HPTLCFootnote

, , , , &
Pages 667-676 | Received 04 Dec 2015, Accepted 03 May 2016, Published online: 16 Apr 2018

References

  • S.VaidyanathanV.JarugulaH.A.DieterichD.HowardW.P.DoleClinical pharmacodynamics and pharmacokinetics of aliskirenClin. Pharmacokinet.472008515531
  • S.MorgantiC.LonatiAliskiren: the first direct rennin inhibitor available for clinical useJ. Nephrol.242011541549
  • S.SenS.SabirliT.OzyigitY.UresinAliskiren: review of efficacy and safety data with focus on past and recent clinical trialsTher. Adv. Chronic Dis.42013232241
  • M.B.HovaterE.A.JaimesOptimizing combination therapy in the management of hypertension: the role of the aliskiren, amlodipine, and hydrochlorothiazide fixed combinationIntegr. Blood Press. Control620135967
  • M.BurnierFixed combinations in the pragmatic management of hypertension: focus on aliskiren and hydrochlorothiazide as a single pillIntegr. Blood Press. Control320105762
  • M.Wrasse-SangoiL.T.SecrettiI.F.DiefenbachC.M.B.RolimM.S.SangoiDevelopment and validation of an UV spectrophotometric method for the determination of aliskiren in tabletsQuim. Nova33201013301334
  • M.A.RamadanM.B.AbuiribanDevelopment and validation of a spectrophotometric method for determination of aliskiren in tablets using o-phthalaldehydeInt. J. Pharm. Sci. Rev. Res.212013333337
  • M.I.EzzeldinE.ShokryM.A.FouadR.I.ElbagaryApplication of chromatographic and spectrophotometric methods for the analysis of aliskiren and hydrochlorothiazide antihypertensive combinationInt. J. Adv. Chem.120131320
  • Z.AydoğmuşSpectrofluorimetric determination of aliskiren in dosage forms and urineLuminescence272012489494
  • Z.AydogmusF.SariS.T.UluSpectrofluorimetric determination of aliskiren in tablets and spiked human plasma through derivatization with dansyl chlorideJ. Fluoresc.222012549556
  • M.S.SangoiM.Wrasse-SangoiP.R.OliveiraC.M.B.RolimM.SteppeSimultaneous determination of aliskiren and hydrochlorothiazide from their pharmaceutical preparations using a validated stability-indicating MEKC methodJ. Sep. Sci.34201118591866
  • M.M.SalimW.M.EbeidN.El-EnanyF.BelalM.WalashG.PatonaySimultaneous determination of aliskiren hemifumarate, amlodipine besylate, and hydrochlorothiazide in their triple mixture dosage form by capillary zone electrophoresisJ. Sep. Sci.37201412061213
  • G.K.SwamyJ.V.L.N.S.RaoJ.M.R.KumarU.A.KumarD.V.R.N.BikshapathiD.V.KumarAnalytical method development and validation of aliskiren in bulk and tablet dosage form by RP-HPLC methodJ. Pharm. Res.42011865867
  • M.S.SangoiM.Wrasse-SangoiP.R.OliveiraV.TodeschiniC.M.B.RolimRapid simultaneous determination of aliskiren and hydrochlorothiazide from their pharmaceutical formulations by monolithic silica HPLC column employing experimental designsJ. Liq. Chromatogr. Relat. Technol.492011170175
  • M.Wrasse-SangoiM.S.SangoiP.R.OliveiraL.T.SecrettiC.M.B.RolimDetermination of aliskiren in tablet dosage forms by a validated stability-indicating RP-LC methodJ. Chromatogr. Sci.492011170175
  • F.BelalM.WalashN.El-EnanyS.ZayedSimultaneous determination of aliskiren and hydrochlorothiazide in tablets and spiked human urine by ion-pair liquid chromatographyPharmazie682013933938
  • F.BelalM.WalashN.El-EnanyS.ZayedHighly sensitive HPLC method for assay of aliskiren in human plasma through derivatization with 1-naphthyl isocyanate using UV detectionJ. Chromatogr. B93320132429
  • V.R.B.VemulaP.K.SharmaI.SinghviA validated RP-HPLC method for determination of aliskiren and amlodipine in tablet dosage formInt. J. Pharm.32013601606
  • R.I.El-BagaryG.PatonayA.A.ElzahrE.F.ElkadyW.A.EbeidIon-pair LC method for simultaneous determination of aliskiren hemifumarate, amolodipine besylate and hydrochlorothiazide in pharmaceuticalsChromatographia772014257264
  • S.S.MannemalaJ.S.NagarajanDevelopment and validation of a HPLC-PDA bioanalytical method for the simultaneous estimation of aliskiren and amlodipine in human plasmaBiomed. Chromatogr.292015346352
  • F.A.OzdemirA.AkyüzSimultaneous determination of amlodipine and aliskren in tablets by high-performance liquid chromatographyJ. Chromatogr. Sci.522014685690
  • V.AdireddyN.R.PilliV.R.DerangulaS.R.SatlaC.V.GanguriV.PonneriLiquid chromatography-tandem mass spectrometric assay for aliskiren, a novel renin inhibitor in micro-volumes of human plasma: a pharmacokinetic application in healthy South Indian male subjectsBiomed. Chromatogr.27201310621069
  • B.B.BurckhardtS.RamusovicJ.TinsS.LaeerDetermination of aliskiren in human serum quantities by HPLC-tandem mass spectrometry appropriate for pediatric trialsBiomed. Chromatogr.272013477486
  • B.B.BurckhardtJ.TinsS.LaeerLiquid chromatography-tandem mass spectrometry of aliskiren in saliva and its application to a clinical trial with healthy volunteersJ. Pharm. Biomed. Anal.962014118126
  • B.B.BurckhardtJ.TinsS.LaeerSimultaneous quantitative and qualitative analysis of aliskiren, enalapril and its active metabolite enalaprilat in undiluted human urine utilizing LC–ESI–MS/MSBiomed. Chromatogr.28201416791691
  • S.MagieraFast, simultaneous quantification of three novel cardiac drugs in human urine by MEPS-UHPLC-MS/MS for therapeutic drug monitoringJ. Chromatogr. B93820138695
  • F.LiuY.XuS.GaoJ.ZhangQ.GuoDetermination of hydrochlorothiazide in human plasma by liquid chromatography/tandem mass spectrometryJ. Pharm. Biomed. Anal.44200711871191
  • M.G.QuagliaE.DonatiG.CarlucciP.MazzeoS.FanaliDetermination of losartan and hydrochlorothiazide in tablets by CE and CECJ. Pharm. Biomed. Anal.292002981987
  • R.M.MaggioP.M.CastellanoT.S.KaufmanA multivariate approach for the simultaneous determination of losartan potassium and hydrochlorothiazide in a combined pharmaceutical tablet formulationAnal. Bioanal. Chem.391200829492955
  • B.H.MehtaS.B.MorgeHPTLC-densitometric analysis of candesartan cilexetil and hydrochlorothiazide in tabletsJ. Planar Chromatogr.212008173176
  • S.S.KadukarS.V.GandhiP.N.RanjaneS.S.RanherHPTLC analysis of olmesartan medoxomil and hydrochlorothiazide in combination tablet dosage formsJ. Planar Chromatogr.222009425428
  • M.A.HegazyF.H.MetwalyM.AbdelkawyN.S.AbdelwahabSpectrophotometric and chemometric determination of hydrochlorothiazide and spironolactone in binary mixture in the presence of their impurities and degradantsDrug Test. Anal.22010243251
  • S.J.JoshiP.A.KarbhariS.I.BhoirK.S.BinduC.DasRP-HPLC method for simultaneous estimation of bisoprolol fumarate and hydrochlorothiazide in tablet formulationJ. Pharm. Biomed. Anal.522010362371
  • H.LiJ.HeQ.LiuZ.HuoS.LiangY.LiangY.ItoSimultaneous determination of hydrochlorothiazide and reserpine in human urine by LC with a simple pre-treatmentChromatographia732011171175
  • I.SalamaSimultaneous HPLC-UV analysis of telmisartan and hydrochlorothiazide in human plasmaBull. Faculty Pharm. Cairo Uni.4920111924
  • B.SatheeshS.K.PulluruK.NitinD.SaravananSimultaneous determination of eprosartan, hydrochlorothiazide and their related compounds in pharmaceutical dosage forms by UPLCJ. Liq. Chromatogr. Relat. Technol.34201118851900
  • D.V.BharathiK.K.HothaP.K.ChatkiV.SatyanarayanaV.VenkateswarluLC–MS/MS method for simultaneous estimation of candesartan and hydrochlorothiazide in human plasma and its use in clinical pharmacokineticsBioanalysis4201211951204
  • A.G.JangidR.H.TaleV.V.VaidyaA single, selective and simple validated method for simultaneous estimation of amiloride and hydrochlorothiazide in human plasma by liquid chromatography–tandem mass spectrometryBiomed. Chromatogr.26201295100
  • X.QiuZ.WangB.WangH.ZhanX.PanR.XuSimultaneous determination of irbesartan and hydrochlorothiazide in human plasma by ultra high performance liquid chromatography tandem mass spectrometry and its application to a bioequivalence studyJ. Chromatogr. B9572014110115
  • ICH Harmonized Tripartite Guideline, Validation of Analytical Procedures: Text and Methodology Q2 (R1), Geneva, November 2005.
  • Guidance for Industry, Bioanalytical Method ValidationMay 2001US Department of Health and Human Services, Food and Drug Administration Centre for Drug Evaluation and Research (CDER), Centre for Veterinary Medicine (CVM)